Latest News and Press Releases

New York, June 05, 2025 (GLOBE NEWSWIRE) -- Huma Therapeutics, the global healthcare AI company, today announced the launch of Hi Scribe, a generative AI clinical documentation tool designed to...

Luton, Bedfordshire, United Kingdom, June 03, 2025 (GLOBE NEWSWIRE) -- Market Overview The global Diagnostic Imaging Clinical Trials Market was valued at USD 12 billion in 2024 and is projected to...

PharmAla makes shipment to Yale, Agrees with Multidisciplinary Association for Psychedelic Studies to publicly post Investigator's Brochure for LaNeo MDMA

WATERTOWN, Mass., May 30, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...

Columbus, OH, May 05, 2025 (GLOBE NEWSWIRE) -- LainaHealth, formerly IncludeHealth, announced today the launch of its transformative virtual care model that pairs licensed physical therapists with...

Urcosimod phase 2 trial treating Neuropathic Corneal Pain (“NCP”) patients was initiated in October 2024 and designed as a double-masked, randomized, 12-week placebo-controlled trial.OKYO Pharma plans...

Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”), a biopharmaceutical company pioneering novel treatments for obesity, today announces the appointment of three new...

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics,...

Webcast scheduled for Tuesday, April 1, 2025 at 8:00 AM ET. BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused...

Anteris Technologies reaches clinical milestone: 100 patients treated with DurAVR® Transcatheter Heart Valve (THV)